Irreversible DNA Polymerase Beta Lyase Inhibitor
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for inhibiting DNA polymerase beta, a key enzyme in base excision repair, are not effective enough in targeting the lyase activity, which is crucial for cancer therapy as it is overexpressed in cancer cells and contributes to tumorigenesis.
Innovation Solution
Development of a compound of formula (I) that irreversibly inhibits the lyase activity of DNA polymerase beta, specifically designed to target the lyase active site, thereby inhibiting cancer cell growth and potentiating the cytotoxic effects of DNA damaging agents.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current inhibition methods are used, then some Pol β activity is suppressed, but the lyase activity is not sufficiently targeted and inhibition effectiveness is limited
Solution Approach 1:
The compound is designed with specific structural features (1,4-dicarbonyl warhead, transition state mimicage) that selectively target the lyase active site of Pol β, creating local chemical interactions that are highly specific to the lyase function rather than general polymerase activity. This localized targeting achieves superior selectivity for lyase inhibition.
Solution Approach 2:
The compound utilizes chemical parameter changes including formation of a covalent Schiff base adduct with Lys72, transition from reversible to irreversible binding, and structural transformation upon enzyme binding. These parameter changes enable potent and specific inhibition of lyase activity.
2Object-affected harmful factors
If Pol β is inhibited to enhance cytotoxicity, then cancer cell sensitivity to DNA damage increases, but off-target effects on normal cells may occur
Solution Approach 1:
The compound converts the harmful overexpression of Pol β in cancer cells into a therapeutic advantage by specifically inhibiting the lyase activity that cancer cells rely on for DNA repair. The inhibition of this repair pathway in Pol β-overexpressing cells enhances their sensitivity to DNA-damaging agents, turning the enzyme's presence into a vulnerability.
Solution Approach 2:
The compound acts as an intermediary that selectively binds to and inhibits Pol β lyase activity in cancer cells with high Pol β expression, thereby mediating enhanced cytotoxicity specifically in these cells while sparing normal cells with lower Pol β levels.
3Reliability
If irreversible inhibition is achieved through covalent bonding, then inhibition potency increases, but selectivity for the lyase site over the polymerase site must be maintained
Solution Approach 1:
The compound first forms a reversible non-covalent complex with the lyase active site, positioning the 1,4-dicarbonyl warhead for optimal attack on Lys72. This preliminary binding ensures correct orientation and proximity before covalent bond formation, thereby ensuring site-selective irreversible inhibition.
Solution Approach 2:
The compound replaces mechanical/physical binding with a chemical covalent bonding mechanism, forming a stable Schiff base adduct with Lys72. This chemical substitution provides irreversible, high-potency inhibition while the molecular design ensures specificity for the lyase site through transition state mimicage and spatial positioning.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The compound significantly inhibits DNA polymerase beta activity, leading to enhanced cytotoxicity in cancer cells, particularly when used in combination with DNA damaging agents, effectively disrupting the base excision repair pathway and sensitizing cells to DNA damage.
Implementation Method 1
Lys72 is the primary amine responsible for Schiff base formation
Implementation Method 2
The compound of formula (I) and pharmaceutically acceptable salts and prodrugs thereof irreversibly inhibit a DNA repair enzyme
Data Source
AI summary
Methods and compounds are disclosed for irreversibly inhibiting a DNA repair enzyme that possesses lyase activity.